Meridian Bioscience logo

Meridian Bioscience VIVO

$ 33.97 0.0%

Quarterly report 2022-Q4
added 02-09-2023

report update icon

Country

usaUSA

IPO year

1986

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. John Kenny

Employees in the company

660

Shares

43.6 M

Market Cap[1]

$ 1.49 B

EBITDA (LTM)

$ 52.9 M

P/E (LTM)

56.62

P/S (LTM)

4.65

EPS (LTM)

0.6

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.